Digital therapeutics (DTx) are changing the healthcare delivery system with evidence-based technologies that improve patient outcomes.Learn About DTx
“Dario has helped me manage my diabetes, because I now know how my body reacts to different foods and meals. Before Dario, my A1c was 9.7. Now its 5.7.”
Richard J., United States
"My panic attacks were terrifying - I couldn’t breathe, my mind went blank, and I felt like I was stuck in a black hole of fear. It’s now been 3 years since I’ve had a panic attack. Freespira gave me my life back.”
Talia, United States
"I've had diabetes for 20 years and I find BlueStar helpful. I like being able to see food options and figure out better choices."
Susan, United States
The ‘DTx Value Assessment & Integration Guide’ provides a first ever industry framework to streamline the process of bringing safe and effective digital therapeutics into clinical use.
The Guide provides the building blocks of DTx product review and economic assessment pathways and serves as a tool for healthcare decision makers (HCDMs) and DTx manufacturers to use in assessing baseline information about DTx products, their value, and their impact in real-world settings.Learn More about the DTx Value Guide
The Digital Therapeutics Alliance is a global non-profit trade association of industry leaders and stakeholders engaged in the advancement of evidence-driven digital therapeutics.
DTA works to broaden the understanding, adoption, and integration of clinically evaluated digital therapeutics into healthcare through education, advocacy, and cross-industry collaboration. DTA maintains an international industry presence and is proud to work with members from 17 countries spread across five continents.Join DTA's Global Efforts
Member organizations play a critical role in transforming healthcare by delivering an impressive array of therapeutic interventions that improve clinical and health economic outcomes. Learn more about DTA and member company contributions.